scholarly journals Postoperative N-terminal pro-brain natriuretic peptide predicts in-hospital mortality after living donor liver transplantation

2020 ◽  
Author(s):  
İsmail Polat Canbolat
Keyword(s):  
Liver Transplantation ◽  
Hospital Mortality ◽  
Brain Natriuretic Peptide ◽  
Natriuretic Peptide ◽  
Living Donor ◽  
Living Donor Liver Transplantation ◽  
Donor Liver ◽  
Donor Liver Transplantation

Effect of Institutional Case Volume on In-hospital Mortality After Living Donor Liver Transplantation

2019 ◽  
Vol 103 (5) ◽  
pp. 952-958 ◽  
Author(s):  
Seokha Yoo ◽  
Eun Jin Jang ◽  
Nam-Joon Yi ◽  
Ga Hee Kim ◽  
Dal Ho Kim ◽  
...  
Keyword(s):  
Liver Transplantation ◽  
Hospital Mortality ◽  
Living Donor ◽  
Living Donor Liver Transplantation ◽  
Donor Liver ◽  
Case Volume ◽  
Donor Liver Transplantation

scholarly journals In-hospital mortality in adult recipients of living donor liver transplantation: Experience of 576 consecutive cases at a single center

2009 ◽  
Vol 15 (11) ◽  
pp. 1420-1425 ◽  
Author(s):  
Toshimi Kaido ◽  
Hiroto Egawa ◽  
Hiroaki Tsuji ◽  
Eishi Ashihara ◽  
Taira Maekawa ◽  
...  
Keyword(s):  
Liver Transplantation ◽  
Hospital Mortality ◽  
Living Donor ◽  
Living Donor Liver Transplantation ◽  
Single Center ◽  
Donor Liver ◽  
Donor Liver Transplantation

Adult-to-Adult Living-Donor Liver Transplantation

Swiss Surgery ◽  
2003 ◽  
Vol 9 (5) ◽  
pp. 227-236 ◽  
Author(s):  
Majno ◽  
Mentha ◽  
Berney ◽  
Bühler ◽  
Giostra ◽  
...  
Keyword(s):  
Liver Transplantation ◽  
Living Donor ◽  
Living Donor Liver Transplantation ◽  
Therapeutic Option ◽  
Donor Liver ◽  
Donor Liver Transplantation ◽  
Multidisciplinary Program ◽  
First Case ◽  
Living Donor Transplantation ◽  
The Right

Living donor liver transplantation is a relatively new procedure in which the right side of the liver is harvested in a healthy donor and transplanted into a recipient. After the first case in 1994, over 3000 cases have been done worldwide. This review summarizes the reasons why the procedure is needed, describes its main technical aspects, highlights the boundaries in which it can be done safely, summarizes the current experience worldwide and describes the main points of the program in our unit. We argue that living-donor transplantation is a viable alternative to a long time on the waiting list for several patients, and it can be performed safely and successfully provided that all precautions are undertaken to minimize the risks in the donor and to increase the chances of a good outcome in the recipients. If these prerequisites are met, and within the framework of a structured multidisciplinary program, we believe that living-donor liver transplantation should be funded by health insurances as a recognized therapeutic option.

Sign in / Sign up

Export Citation Format

Share Document